Luca Roz

9.3k total citations · 2 hit papers
76 papers, 4.6k citations indexed

About

Luca Roz is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Luca Roz has authored 76 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 39 papers in Oncology and 31 papers in Cancer Research. Recurrent topics in Luca Roz's work include Cancer Cells and Metastasis (21 papers), Cancer Genomics and Diagnostics (15 papers) and MicroRNA in disease regulation (10 papers). Luca Roz is often cited by papers focused on Cancer Cells and Metastasis (21 papers), Cancer Genomics and Diagnostics (15 papers) and MicroRNA in disease regulation (10 papers). Luca Roz collaborates with scholars based in Italy, United States and United Kingdom. Luca Roz's co-authors include Gabriella Sozzi, Ugo Pastorino, Davide Conte, Francesca Andriani, Giulia Bertolini, Luigi Mariani, Carla Verri, Elisa Calabrò, Mattia Boeri and Carlo M. Croce and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Luca Roz

75 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Highly tumorigenic lung cancer CD133 ⁺ cells display stem-like features and are spared by cisplatin treatment

2009 652 citations Giulia Bertolini, Luca Roz et al. profile →
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

2011 568 citations Mattia Boeri, Carla Verri et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luca Roz Italy	33	2.6k	2.1k	1.8k	1.1k	384	76	4.6k
M. OʼReilly United States	14	3.7k 1.4×	2.2k 1.0×	1.9k 1.0×	741 0.7×	273 0.7×	30	6.0k
Joana Paredes Portugal	40	2.6k 1.0×	1.2k 0.6×	1.9k 1.1×	577 0.5×	533 1.4×	95	4.5k
Amaia Lujambio United States	27	4.2k 1.6×	2.8k 1.3×	1.2k 0.7×	631 0.6×	332 0.9×	54	6.1k
Alicia Viloria‐Petit Canada	23	2.4k 0.9×	1.3k 0.6×	1.4k 0.8×	704 0.6×	188 0.5×	48	3.8k
George N. Naumov United States	22	1.9k 0.7×	1.1k 0.5×	2.3k 1.3×	1.3k 1.2×	204 0.5×	37	4.0k
Thierry Maudelondé France	41	2.2k 0.8×	1.9k 0.9×	2.2k 1.2×	551 0.5×	321 0.8×	125	5.1k
Patrizia Casalini Italy	38	3.0k 1.2×	2.5k 1.2×	1.7k 1.0×	462 0.4×	363 0.9×	79	5.3k
Dieter Niederacher Germany	38	2.4k 0.9×	1.4k 0.7×	1.6k 0.9×	408 0.4×	432 1.1×	143	4.2k
Kathy Q. Cai United States	34	2.2k 0.9×	940 0.4×	1.0k 0.6×	936 0.9×	304 0.8×	117	3.7k
Manuela Campiglio Italy	30	4.8k 1.8×	3.6k 1.7×	2.0k 1.1×	499 0.5×	210 0.5×	60	6.7k

Countries citing papers authored by Luca Roz

Since Specialization

Citations

This map shows the geographic impact of Luca Roz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Roz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Roz more than expected).

Fields of papers citing papers by Luca Roz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Roz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Roz. The network helps show where Luca Roz may publish in the future.

Co-authorship network of co-authors of Luca Roz

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Roz. A scholar is included among the top collaborators of Luca Roz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Roz. Luca Roz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salviato, Elisa, Endre Sebestyén, Mirko Riboni, et al.. (2023). Leveraging Tissue-Specific Enhancer–Target Gene Regulatory Networks Identifies Enhancer Somatic Mutations That Functionally Impact Lung Cancer. Cancer Research. 84(1). 133–153. 2 indexed citations

Torres‐Martínez, Susana, Silvia Calabuig‐Fariñas, Giulia Bertolini, et al.. (2023). Soluble galectin‐3 as a microenvironment‐relevant immunoregulator with prognostic and predictive value in lung adenocarcinoma. Molecular Oncology. 18(1). 190–215. 3 indexed citations

Bertolini, Giulia, et al.. (2022). Click Chemistry Protocol for 3D Bioprintable Elastin−Hyaluronic Acid Hydrogels. ChemNanoMat. 9(2). 6 indexed citations

Gabasa, Marta, Evette S. Radisky, Giulia Bertolini, et al.. (2021). MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescence. Cancer Letters. 507. 1–12. 40 indexed citations

Russo, Laura, Laura Cipolla, Massimo Moro, et al.. (2020). Differential glycosylation of collagen modulates lung cancer stem cell subsets through β1 integrin‐mediated interactions. Cancer Science. 112(1). 217–230. 32 indexed citations

Andriani, Francesca, Mavis Mensah, Federica Facchinetti, et al.. (2018). Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer. BMC Cancer. 18(1). 899–899. 41 indexed citations

Moro, Massimo, Giulia Bertolini, Roberto Caserini, et al.. (2017). Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness. Scientific Reports. 7(1). 6689–6689. 34 indexed citations

Tassi, Elena, Giulia Grazia, Claudia Vegetti, et al.. (2016). Early Effector T Lymphocytes Coexpress Multiple Inhibitory Receptors in Primary Non–Small Cell Lung Cancer. Cancer Research. 77(4). 851–861. 44 indexed citations

Valtorta, Silvia, Massimo Moro, Giulia Bertolini, et al.. (2016). Metabolic Evaluation of Non–Small Cell Lung Cancer Patient–Derived Xenograft Models Using ¹⁸F-FDG PET: A Potential Tool for Early Therapy Response. Journal of Nuclear Medicine. 58(1). 42–47. 6 indexed citations

10.

Bertolini, Giulia, Lucia D’Amico, Massimo Moro, et al.. (2015). Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM− Lung Cancer–Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis. Cancer Research. 75(17). 3636–3649. 79 indexed citations

11.

Verdura, Sara, Ilse Zondervan, Federica Facchinetti, et al.. (2015). PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion. Cancer Research. 75(7). 1287–1297. 38 indexed citations

12.

Sozzi, Gabriella, Mattia Boeri, Marta Rossi, et al.. (2014). Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study. Journal of Clinical Oncology. 32(8). 768–773. 318 indexed citations

13.

Fortunato, Orazio, Mattia Boeri, Massimo Moro, et al.. (2014). Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction. Cell Death and Disease. 5(12). e1564–e1564. 68 indexed citations

14.

Verri, Carla, Luca Roz, Davide Conte, et al.. (2008). Fragile Histidine Triad Gene Inactivation in Lung Cancer: The European Early Lung Cancer Project. American Journal of Respiratory and Critical Care Medicine. 179(5). 396–401. 52 indexed citations

15.

Sozzi, Gabriella, Luca Roz, Davide Conte, et al.. (2008). Plasma DNA Quantification in Lung Cancer Computed Tomography Screening. American Journal of Respiratory and Critical Care Medicine. 179(1). 69–74. 83 indexed citations

16.

Cortinovis, Diego, Francesca Andriani, Alessandra Fabbri, et al.. (2008). FHIT and p53 Status and Response to Platinum-Based Treatment in Advanced Non-Small Cell Lung Cancer. Current Cancer Drug Targets. 8(5). 342–348. 10 indexed citations

17.

Cavazzoni, Andrea, Maricla Galetti, Claudia Fumarola, et al.. (2006). Effect of inducible FHIT and p53 expression in the Calu-1 lung cancer cell line. Cancer Letters. 246(1-2). 69–81. 15 indexed citations

18.

Roz, Luca, Francesca Andriani, Carlos Gil Ferreira, Giuseppe Giaccone, & Gabriella Sozzi. (2004). The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression. Oncogene. 23(56). 9102–9110. 30 indexed citations

19.

Sozzi, Gabriella, et al.. (2002). Involvement of FHIT in lung carcinogenesis prospects for future clinical gene therapy applications.. PubMed. 1(4). S62–S62. 1 indexed citations

20.

Wu, Chu, Luca Roz, Philip Sloan, et al.. (1997). Deletion mapping defines three discrete areas of allelic imbalance on chromosome arm 8p in oral and oropharyngeal squamous cell carcinomas. Genes Chromosomes and Cancer. 20(4). 347–353. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact